996 related articles for article (PubMed ID: 31842912)
21.
Stuchi LP; Castanhole-Nunes MMU; Maniezzo-Stuchi N; Biselli-Chicote PM; Henrique T; Padovani Neto JA; de-Santi Neto D; Girol AP; Pavarino EC; Goloni-Bertollo EM
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32824922
[TBL] [Abstract][Full Text] [Related]
22. Integrative Analysis of Potential Biomarkers Involved in the Progression of Papillary Thyroid Cancer.
Bansal R; Saxena U
Appl Biochem Biotechnol; 2023 May; 195(5):2917-2932. PubMed ID: 36445679
[TBL] [Abstract][Full Text] [Related]
23. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Zhao H; Li H
Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
[TBL] [Abstract][Full Text] [Related]
24. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
25. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
[TBL] [Abstract][Full Text] [Related]
26. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.
Cheng Q; Chen X; Wu H; Du Y
J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587
[TBL] [Abstract][Full Text] [Related]
27. An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.
Yi W; Liu J; Qu S; Fan H; Lv Z
Technol Cancer Res Treat; 2020; 19():1533033820965594. PubMed ID: 33054579
[TBL] [Abstract][Full Text] [Related]
28. Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma.
Xin Y; Meng K; Guo H; Chen B; Zheng C; Shou X; Yu K
Comb Chem High Throughput Screen; 2022; 25(5):819-830. PubMed ID: 33550967
[TBL] [Abstract][Full Text] [Related]
29. NR2F1-AS1 regulated miR-423-5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma.
Yang C; Liu Z; Chang X; Xu W; Gong J; Chai F; Cui D
J Cell Biochem; 2020 Feb; 121(2):2009-2018. PubMed ID: 31692033
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of lncRNA-mediated ceRNA network in papillary thyroid cancer.
Sun Y; Dai WR; Xia N
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10003-10014. PubMed ID: 33090405
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer.
Liu C; Pan Y; Li Q; Zhang Y
Int J Med Sci; 2021; 18(15):3478-3487. PubMed ID: 34522174
[No Abstract] [Full Text] [Related]
32. Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles.
Wei S; Yun X; Ruan X; Wei X; Zheng X; Gao M
Oncol Lett; 2019 Dec; 18(6):6670-6678. PubMed ID: 31814850
[TBL] [Abstract][Full Text] [Related]
33. Integrated Bioinformatics Analysis of mRNAs and miRNAs Identified Potential Biomarkers of Oral Squamous Cell Carcinoma.
Amiri-Dashatan N; Koushki M; Jalilian A; Ahmadi NA; Rezaei-Tavirani M
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1841-1848. PubMed ID: 32597160
[TBL] [Abstract][Full Text] [Related]
34. Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling.
Akyay OZ; Gov E; Kenar H; Arga KY; Selek A; Tarkun İ; Canturk Z; Cetinarslan B; Gurbuz Y; Sahin B
OMICS; 2020 Mar; 24(3):148-159. PubMed ID: 32073999
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
[TBL] [Abstract][Full Text] [Related]
36. Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools.
Canturk KM; Ozdemir M; Can C; Öner S; Emre R; Aslan H; Cilingir O; Ciftci E; Celayir FM; Aldemir O; Özen M; Artan S
Mol Biol Rep; 2014 Dec; 41(12):8127-35. PubMed ID: 25189652
[TBL] [Abstract][Full Text] [Related]
37. Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma.
Han J; Chen M; Wang Y; Gong B; Zhuang T; Liang L; Qiao H
Sci Rep; 2018 Jul; 8(1):9912. PubMed ID: 29967488
[TBL] [Abstract][Full Text] [Related]
38. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.
Gulfidan G; Soylu M; Demirel D; Erdonmez HBC; Beklen H; Ozbek Sarica P; Arga KY; Turanli B
Arch Biochem Biophys; 2022 Jan; 715():109085. PubMed ID: 34800440
[TBL] [Abstract][Full Text] [Related]
39. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
40. hsa-miR-206b Involves in the Development of Papillary Thyroid Carcinoma via Targeting LMX1B.
Lu H; Zhu C; Ruan Y; Fan L; Ruan Z; Chen Q; Yuan J; Xu Y; Wang H; Wei Q
Biomed Res Int; 2022; 2022():7488708. PubMed ID: 35342753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
